SecFilingDex

Summit Therapeutics Inc.

43 SEC EDGAR filings indexed (CIK 0001599298) across 10 form types.

Filing profile

Summit Therapeutics Inc. (SMMT) has 43 SEC filings indexed on SecFilingDex, across 10 form types filed over roughly 3 years, from September 8, 2023 to August 26, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 25 of these filings were disclosed in the twelve months to August 26, 2026. 1 of the 43 is an amendment (a corrected or updated version of an earlier filing).

Disclosure mix

  • 88-KMaterial event · event-driven
  • 810-QQuarterly report · quarterly
  • 8Form 4Insider transaction · within 2 business days of transaction
  • 4424B5Prospectus supplement · event-driven
  • 4DEF 14AProxy statement · annual (pre-meeting)
  • 310-KAnnual report · annual
  • 3Form 3Initial insider ownership · within 10 days of becoming an insider
  • 2DEFA14ASEC filing
  • 2PRE 14ASEC filing
  • 1SC 13D/A5%+ activist stake · event-driven (within 10 days)

Profile derived from 43 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1599298&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.